290 related articles for article (PubMed ID: 29350068)
1. Primary Liver Cancers-Part 1: Histopathology, Differential Diagnoses, and Risk Stratification.
Jiang K; Al-Diffhala S; Centeno BA
Cancer Control; 2018; 25(1):1073274817744625. PubMed ID: 29350068
[TBL] [Abstract][Full Text] [Related]
2. [Hepatocellular carcinoma and cholangiocarcinoma--different prognosis, pathogenesis and therapy].
Tischoff I; Tannapfel A
Zentralbl Chir; 2007 Aug; 132(4):300-5. PubMed ID: 17724632
[TBL] [Abstract][Full Text] [Related]
3. Preneoplastic lesions in the liver: Molecular insights and relevance for clinical practice.
Desjonqueres E; Campani C; Marra F; Zucman-Rossi J; Nault JC
Liver Int; 2022 Mar; 42(3):492-506. PubMed ID: 34982503
[TBL] [Abstract][Full Text] [Related]
4. Primary Liver Cancers, Part 2: Progression Pathways and Carcinogenesis.
Jiang K; Centeno BA
Cancer Control; 2018; 25(1):1073274817744658. PubMed ID: 29353494
[TBL] [Abstract][Full Text] [Related]
5. [Selective deposition of agrin in the microvasculature of hepatocellular carcinoma: aspects in pathogenesis and differential diagnosis].
Tátrai P
Magy Onkol; 2008 Dec; 52(4):379-83. PubMed ID: 19068466
[TBL] [Abstract][Full Text] [Related]
6. The alphavbeta6 integrin is a highly specific immunohistochemical marker for cholangiocarcinoma.
Patsenker E; Wilkens L; Banz V; Osterreicher CH; Weimann R; Eisele S; Keogh A; Stroka D; Zimmermann A; Stickel F
J Hepatol; 2010 Mar; 52(3):362-9. PubMed ID: 20137822
[TBL] [Abstract][Full Text] [Related]
7. Synchronous hepatocellular carcinoma and cholangiocarcinoma arising in two different dysplastic nodules.
Kwon Y; Lee SK; Kim JS; Ro JY; Yu E
Mod Pathol; 2002 Oct; 15(10):1096-101. PubMed ID: 12379757
[TBL] [Abstract][Full Text] [Related]
8. Fine needle aspiration biopsy of hepatocellular carcinoma and hepatocellular nodular lesions: role, controversies and approach to diagnosis.
Wee A
Cytopathology; 2011 Oct; 22(5):287-305. PubMed ID: 21762411
[TBL] [Abstract][Full Text] [Related]
9. Evaluating Liver Biopsies with Well-Differentiated Hepatocellular Lesions.
Umetsu SE; Kakar S
Surg Pathol Clin; 2023 Sep; 16(3):581-598. PubMed ID: 37536890
[TBL] [Abstract][Full Text] [Related]
10. Hepatic adenoma and focal nodular hyperplasia.
Shortell CK; Schwartz SI
Surg Gynecol Obstet; 1991 Nov; 173(5):426-31. PubMed ID: 1658955
[TBL] [Abstract][Full Text] [Related]
11. [Differential diagnosis of focal liver lesions with MRI using the superparamagnetic contrast medium endorem].
Vogl TJ; Hammerstingl R; Keck H; Felix R
Radiologe; 1995 Nov; 35(11 Suppl 2):S258-66. PubMed ID: 8588032
[TBL] [Abstract][Full Text] [Related]
12. Staging and Prognostic Models for Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.
Burkhart RA; Pawlik TM
Cancer Control; 2017; 24(3):1073274817729235. PubMed ID: 28975828
[TBL] [Abstract][Full Text] [Related]
13. Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules.
Terzi E; Iavarone M; Pompili M; Veronese L; Cabibbo G; Fraquelli M; Riccardi L; De Bonis L; Sangiovanni A; Leoni S; Zocco MA; Rossi S; Alessi N; Wilson SR; Piscaglia F;
J Hepatol; 2018 Mar; 68(3):485-492. PubMed ID: 29133247
[TBL] [Abstract][Full Text] [Related]
14. Claudin-7 protein differentiates canine cholangiocarcinoma from hepatocellular carcinoma.
Jakab C; Kiss A; Schaff Z; Szabó Z; Rusvai M; Gálfi P; Szabára A; Sterczer A; Kulka J
Histol Histopathol; 2010 Jul; 25(7):857-64. PubMed ID: 20503174
[TBL] [Abstract][Full Text] [Related]
15. Cholangiocarcinoma: Classification, Histopathology and Molecular Carcinogenesis.
Lendvai G; Szekerczés T; Illyés I; Dóra R; Kontsek E; Gógl A; Kiss A; Werling K; Kovalszky I; Schaff Z; Borka K
Pathol Oncol Res; 2020 Jan; 26(1):3-15. PubMed ID: 30448973
[TBL] [Abstract][Full Text] [Related]
16. Differential diagnosis of malignant epithelial tumours in the liver: an immunohistochemical study on liver biopsy material.
Al-Muhannadi N; Ansari N; Brahmi U; Satir AA
Ann Hepatol; 2011; 10(4):508-15. PubMed ID: 21911893
[TBL] [Abstract][Full Text] [Related]
17. A practical diagnostic approach to hepatic masses.
Vyas M; Jain D
Indian J Pathol Microbiol; 2018; 61(1):2-17. PubMed ID: 29567877
[TBL] [Abstract][Full Text] [Related]
18. The utility of hepatocyte paraffin 1 antibody in the immunohistological distinction of hepatocellular carcinoma from cholangiocarcinoma and metastatic carcinoma.
Shiran MS; Isa MR; Sherina MS; Rampal L; Hairuszah I; Sabariah AR
Malays J Pathol; 2006 Dec; 28(2):87-92. PubMed ID: 18376797
[TBL] [Abstract][Full Text] [Related]
19. The multidisciplinary management of gastrointestinal cancer. The diagnostic and therapeutic approach for primary solid liver tumours in adults.
Verslype C; Libbrecht L
Best Pract Res Clin Gastroenterol; 2007; 21(6):983-96. PubMed ID: 18070699
[TBL] [Abstract][Full Text] [Related]
20. Atypical large well-differentiated hepatocellular carcinoma with benign nature: a new clinical entity.
Kudo M
Intervirology; 2004; 47(3-5):227-37. PubMed ID: 15383732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
